Clinical Trial Services

Contract Research Organization (CRO)

We offer a variety of clinical trial services and are a full-service Contract Research Organization (CRO). We have over 40 years of experience designing and executing clinical trials, ranging from early feasibility studies to multinational, controlled pivotal trials to post-market registries.

START YOUR PROJECT DISCUSSION

With our extensive experience conducting clinical trials, we can help you design and complete studies that collect the right data, in a cost-effective way. Wherever possible, we recommend designing streamlined studies that generate only the data necessary to achieve your goals, not overloaded with extraneous data that is “nice” to have.  In short, we prefer pragmatic studies to conventional trials. Pragmatic trials take advantage of typical clinical practice to provide insight into real-world results. We understand the unique demands of clinical trials and have dealt with nearly every challenge imaginable. That hard-earned wisdom has led to MED’s proven strategies to develop effective clinical studies that anticipate and avoid potential problems. When conducting a clinical trial, we actively monitor not just the data, but study site performance and compliance with applicable regulatory requirements in order to identify emerging trends. We work with study site investigators and staff to find workable solutions to issues and address them in a timely manner. The resulting relationships also serve to keep the study sites engaged with your study, which promotes better enrollment timelines and more complete, accurate data. In all, we work to maximize each study’s chance of success.

Our Clinical Trial Services team:

• has managed clinical trials with more than 2500 patients at 50+ trial sites in 10 countries;
• has managed clinical trials in a variety of disciplines, such as, but not limited to, interventional radiology/vascular surgery, wound care, soft tissue surgery, cardiology, urology, otolaryngology, head and neck surgery, rheumatology, endocrinology, and cell therapy;
• has designed feasibility trials for novel treatments of a variety of diseases, including, but not limited to, aortic aneurysms, aortic dissections, peripheral vascular disease and critical limb ischemia, chronic dry eye, ventral hernia, hiatal hernia, critical care, and chronic diabetic wounds; and
• is cross-trained, with experience in managing clinical trials residing within the engineering team, regulatory team, and business operations, as well as the company president.